Middle-East & Africa Genetic Testing Market by Type (Carrier Testing, Diagnostic Testing, Prenatal Testing and Neonatal Testing), by Application (Cancer Testing, Pharmacogenomics testing, Prenatal testing and Predisposition testing), and by Region – Industry Analysis, Size, Share, Growth, Trends, and Forecast (2016 – 2021)

Middle-East & Africa Genetic Testing Market by Type (Carrier Testing, Diagnostic Testing, Prenatal Testing and Neonatal Testing), by Application (Cancer Testing, Pharmacogenomics testing, Prenatal testing and Predisposition testing), and by Region – Industry Analysis, Size, Share, Growth, Trends, and Forecast (2016 – 2021)

ID: 41 | Pages: 140 | December 2016 | Region: Middle East and Africa


Currently the genetic testing is the most attractive market among the different segments of molecular diagnostics as the need providing a better healthcare is growing. It is the most sophisticated form of medical testing where even the slightest modification in chromosomes, genes, or proteins which are associated with inherited disease conditions are identified. The market for genetic testing in the Middle-East & Africa is $ 2.626 million in 2015 and is estimated to reach $ 3.622 Million by 2020 growing at a CAGR of 6.649%.

Genetic testing is the study of DNA to predict the susceptibility of a diseases, its diagnosis, or determine the likely course of a disease. Genetic testing has led to an easy diagnosis of diseases, such as sickle cell anaemia, haemophilia, and cystic fibrosis, helping many patients living a normal life.

The primary reasons for the growth of the genetic testing market is attributed to the growing awareness among the individuals about the benefits and the potential it has. Some other drivers that aid in the growth of the genetic testing market are, new innovations in the genetic testing space, increase in the aging population, rise in the number of chronic diseases cases, and rising incidences of cancer cases.

However, there are few hurdles that hinder the growth of the market like, the high costs associated with genetic testing being one. There are concerns among the individuals regarding the authenticity of genetic reports due to credibility of standard procedure.

The genetic testing market in Middle-East & Africa is categorized, based on application into Cancer Testing, Pharmacogenomics testing, Prenatal testing and Predisposition testing. Based on type of tests, the market is segmented into Carrier Testing, Diagnostic Testing, Prenatal Testing and Neonatal Testing. Genetic testing for cancer is predicted to have a high growth rate, and is likely to lead the genetic testing market in the near future. The market for new-borns screening, rare and fatal disorders diagnosing, and estimating the probability of occurrence of diseases is expected to expand. Particularly, genetic tests to screen the new-borns are likely to expand immensely over the coming years.

Furthermore, on the basis of geography, the MEA Market is segmented and analysed under major regions of Middle -East and Africa.

New opportunities for genetic and its related applications are likely to grow owing to the increasing incidences of genetic diseases. The transformation from being a service-driven market to a product-driven market is anticipated to provide a push to the diagnostic companies for the expansion of their operations.

Some of the major companies in the Middle-East & Africa genetic testing market include, Abbott Laboratories, Roche Molecular Diagnostics Inc., Abbott Molecular Inc., AutoGenomics Inc., Celera Group, ELITech Group, BioRad Laboratories, PerkinElmer Inc., Roche Diagnostics Corp., Quest Diagnostics Inc., Transgenomic Inc. and Applied Biosystems Inc.,

1.Introduction                  

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods           

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction              

                2.2 Analysis Design         

                2.3 Research Phases      

                                2.3.1 Secondary Research

                                2.3.2 Primary Research

                                2.3.3 Econometric Modelling

                                2.3.4 Expert Validation

                2.4 Study Timeline          

3. Overview                      

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                      

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market

5. Market Segmentation                              

                5.1 By Type        

                                5.1.1 Carrier Testing

                                5.1.2 Diagnostic Testing

                                5.1.3 Prenatal Testing

                                5.1.4 Neonatal Testing

                5.2 By Application           

                                5.2.1 Cancer Testing

                                5.2.2 Prenatal Testing

                                5.2.3 Pharmacogenomics Testing

                                5.2.4 Presdisposition Testing

6. Geographical Analysis                              

                6.1 Introduction              

                6.2 Middle East

                6.3 Africa            

7.Strategic Analysis                        

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8.Market Leaders' Analysis                          

                8.1 Roche Molecular Diagnostics Inc.      

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis

                                8.1.5 Legal issues

                                8.1.6 Recent Developments

                                8.1.7 SWOT analysis

                                8.1.8 Analyst View

                8.2 Abbott Laboratories

                8.3 AutoGenomics Inc. 

                8.4 Celera Group             

                8.5 ELITech Group          

                8.6 BioRad Laboratories

                8.7 Quest Diagnostics Inc             

                8.8 Transgenomic Inc.   

                8.9 Applied Biosystems Inc.,       

                8.10 PerkinElmer Inc      

9.Competitive Landscape                            

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures          

                9.4 New Product Launches          

10.Expert Opinions                         

                10.1 Market Outlook     

                10.2 Investment Opportunities 

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Middle East & Africa Genetic Testing Market By Region, From 2015-2020 ( USD Million )
  2. Middle East & Africa Genetic Testing Market By Type, From 2015-2020 ( USD Million )
  3. Middle East & Africa Carrier Testing Market By Region, From 2015-2020 ( USD Million )
  4. Middle East & Africa Diagnostic Testing Market By Region, From 2015-2020 ( USD Million )
  5. Middle East & Africa Prenatal Testing Market By Region, From 2015-2020 ( USD Million )
  6. Middle East & Africa Neonatal Testing Market By Region, From 2015-2020 ( USD Million )
  7. Middle East & Africa Genetic Testing Market By Application, From 2015-2020 ( USD Million )
  8. Middle East & Africa Cancer Testing Market By Region, From 2015-2020 ( USD Million )
  9. Middle East & Africa Prenatal Testing Market By Region, From 2015-2020 ( USD Million )
  10. Middle East & Africa Pharmacogenomics Testing Market By Region, From 2015-2020 ( USD Million )
  11. Middle East & Africa Predisposition Testing Market By Region, From 2015-2020 ( USD Million )
  12. Middle East Genetic Testing Market By Type, From 2015-2020 ( USD Million )
  13. Middle East Genetic Testing Market By Application, From 2015-2020 ( USD Million )
  14. Africa Genetic Testing Market By Type, From 2015-2020 ( USD Million )
  15. Africa Genetic Testing Market By Application, From 2015-2020 ( USD Million )
Middle East And Africa Blood Screening Market By Technology (Nucleic Acid Amplification, (rPCR), ELISA, (CLIA, Fluorescence Assay), Rapid Test, NGS, Western Blotting), Product (Instrument, Reagent & Kits, Software) ...
Latin America Blood Screening Market By Technology (Nucleic Acid Amplification, (rPCR), ELISA, (CLIA, Fluorescence Assay), Rapid Test, NGS, Western Blotting), Product (Instrument, Reagent & Kits, Software) & End Use...
Asia Pacific Blood Screening Market By Technology (Nucleic Acid Amplification, (rPCR), ELISA, (CLIA, Fluorescence Assay), Rapid Test, NGS, Western Blotting), Product (Instrument, Reagent & Kits, Software) & End User...
Europe Blood Screening Market By Technology (Nucleic Acid Amplification, (rPCR), ELISA, (CLIA, Fluorescence Assay), Rapid Test, NGS, Western Blotting), Product (Instrument, Reagent & Kits, Software) & End User (Bloo...
North America Blood Screening Market By Technology (Nucleic Acid Amplification, (rPCR), ELISA, (CLIA, Fluorescence Assay), Rapid Test, NGS, Western Blotting), Product (Instrument, Reagent & Kits, Software) & End Use...
Blood Screening Market By Technology (Nucleic Acid Amplification, (rPCR), ELISA, (CLIA, Fluorescence Assay), Rapid Test, NGS, Western Blotting), Product (Instrument, Reagent & Kits, Software) And End User (Blood Ban...
Middle East And Africa Antinuclear Antibody Test Market By Disease (SLE, Rheumatoid Arthritis), By Technique (Immunofluorescence, Multiplex, ELISA), By Product (Software, Systems, Services, Reagents & Assay Kits), B...
Latin America Antinuclear Antibody Test Market By Disease (SLE, Rheumatoid Arthritis), By Technique (Immunofluorescence, Multiplex, ELISA), By Product (Software, Systems, Services, Reagents & Assay Kits), By End Use...
Asia Pacific Antinuclear Antibody Test Market By Disease (SLE, Rheumatoid Arthritis), By Technique (Immunofluorescence, Multiplex, ELISA), By Product (Software, Systems, Services, Reagents & Assay Kits), By End User...
Europe Antinuclear Antibody Test Market By Disease (SLE, Rheumatoid Arthritis), By Technique (Immunofluorescence, Multiplex, ELISA), By Product (Software, Systems, Services, Reagents & Assay Kits), By End User (Hosp...
North America Antinuclear Antibody Test Market By Disease (SLE, Rheumatoid Arthritis), By Technique (Immunofluorescence, Multiplex, ELISA), By Product (Software, Systems, Services, Reagents & Assay Kits), By End Use...
Antinuclear Antibody Test Market By Disease (SLE, Rheumatoid Arthritis), By Technique (Immunofluorescence, Multiplex, ELISA), By Product (Software, Systems, Services, Reagents & Assay Kits), By End User (Hospitals, ...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.